• Wed news: BioNTech buying Biotheus. FDA’s Califf lists hopes for his successor. Amgen loses $12B market cap from hidden spreadsheet tab. TRex Bio raises $84M. London is Europe’s life science capitol. See more on our front page

No smoke without fire?





















And there will be more in Basel after this week's 800. Projecting that Basel reduces by 40-50%.
Next target is Germany ......
Even the low cost sites are not safe with outsourced vendors being asked to take over all services
By the way, NVS really cares about patients and employees, BS at it's best!!
 




And there will be more in Basel after this week's 800. Projecting that Basel reduces by 40-50%.
Next target is Germany ......
Even the low cost sites are not safe with outsourced vendors being asked to take over all services
By the way, NVS really cares about patients and employees, BS at it's best!!
It is about 2000 in total including attrition and those let go this year too! The Indians must be happy they’ll get the new roles!
 








And there will be more in Basel after this week's 800. Projecting that Basel reduces by 40-50%.
Next target is Germany ......
Even the low cost sites are not safe with outsourced vendors being asked to take over all services
By the way, NVS really cares about patients and employees, BS at it's best!!

RW doesn’t have a clue. Hatchet man without a strategy.. NVS is led by McKinsey, why wouldn’t you want to make money.